Affiliation:
1. Transplantation Biology Section, National Cancer Institute, Bethesda, Maryland 20892.
Abstract
The use of allogeneic bone marrow transplantation as a means of inducing donor-specific tolerance across MHC barriers could provide an immunologically specific conditioning regimen for organ transplantation. However, a major limitation to this approach is the toxicity of whole body irradiation as currently used to abrogate host resistance and permit marrow engraftment. The present study describes methodology for abrogating host resistance and permitting marrow engraftment without lethal irradiation. Our preparative protocol involves administration of anti-CD4 and anti-CD8 mAbs in vivo, 300-rad WBI, 700-rad thymic irradiation, and unmanipulated fully MHC-disparate bone marrow. B10 mice prepared by this regimen developed stable mixed lymphohematopoetic chimerism without any clinical evidence of graft-vs.-host disease. Engraftment was accompanied by induction of specific tolerance to donor skin grafts (B10.D2), while third-party skin grafts (B10.BR) were promptly rejected. Mice treated with the complete regimen without bone marrow transplantation appeared healthy and enjoyed long-term survival. This study therefore demonstrates that stable mixed chimerism with donor-specific tolerance can be induced across an MHC barrier after a nonlethal preparative regimen, without clinical GVHD and without the risk of aplasia.
Publisher
Rockefeller University Press
Subject
Immunology,Immunology and Allergy
Cited by
606 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Unlocking Transplant Tolerance with Biomaterials;Advanced Healthcare Materials;2024-07-03
2. Tolerance in intestinal transplantation;Human Immunology;2024-05
3. Intra-Bone Bone Marrow Transplantation;Glycoimmunology in Xenotransplantation;2024
4. Strategies to induce tolerance;Living Donor Organ Transplantation;2024
5. The Future of Heart and Lung Transplantation;Textbook of Transplantation and Mechanical Support for End‐Stage Heart and Lung Disease;2023-09-08